🎯 check Palbociclib (PD-0332991) product page
Palbociclib is a potent CDK4/6 inhibitor. It affects CDK-Rb-E2F signaling by blocking Rb phosphorylation, inducing G1 arrest.
Palbociclib (PD-0332991) Mechanism of Action: CDK4/6 Inhibition in Breast Cancer Cell Research
Palbociclib (PD-0332991) MOA：Targeting CDK4/6 / Rb Pathway for Clinical Trials and Real-World Efficacy in Metastatic Breast Cancer